Guidelines have been issued under section 100A(1) of the Assisted Reproductive Treatment Act 2008 by the Secretary to the Department of Health and Human Services.
The Assisted Reproductive Treatment Act 2008 (Vic) (Act) prohibits taking donated gametes, or embryos produced from donated gametes, into or outside of Victoria without the written approval of the Victorian Assisted Reproductive Authority (VARTA). Accordingly, approval must be obtained from VARTA before:
• the import of donor gametes, or embryos produced from donor gametes, into Victoria from interstate or overseas;
VARTA strongly encourages people considering surrogacy to make these arrangements within Australia. The unregulated environments that occur overseas can pose potentially serious risk or disadvantage for all parties involved in surrogacy arrangements – in particular, for resulting children. However, recognising that international arrangements do occur, the following checklist has been compiled in collaboration with Kellehers Australia. This checklist is a modification of the checklist devised and created by Kellehers Australia.
Intra-cytoplasmic sperm injection (ICSI) is used for the same reasons as IVF, but especially to overcome sperm problems. Essentially, ICSI follows the same process as IVF, except ICSI involves the direct injection of a single sperm into each egg to achieve fertilisation.
The Authority aims to work continuously towards regulatory best practice in administering aspects of the Act in a transparent way. In 2014, the Minister for Health issued a Ministerial Statement of Expection to the Authority in relation to its regulatory functions.
Researched and written by Jacqui Tomlins, and partially funded by VARTA, this resource provides the ideas, suggestions, advice and collective wisdom shared by a broad range of parents from rainbow families.
Resource kit for rainbow families
Objectives: To describe the outcomes of surrogacy among Australian intended parents who engage in compensated surrogacy overseas.
Design, setting and participants: Members of two Australian parenting support forums who were considering surrogacy or were currently or previously in a surrogacy arrangement were invited to complete an anonymous online survey during July 2013.
This brochure was developed with the help from experts in the IVF field. In the hands of experts, IVF procedures are safe and medical complications are rare. But as with all medical procedures, there are some possible health effects. This brochure provides an overview of the possible physical and emotional health effects of IVF for men and women, and outcomes for children born as a result of treatment. The information refers to IVF and intracytoplasmic sperm injection (ICSI).
This brochure is intended as a general introduction to preimplantation genetic testing (PGT): what it is, how it is done, the reasons for doing PGT, and advantages and disadvantages of PGT. It should not be seen as a substitute for advice from doctors or other health professionals. Information contained in this brochure was correct at the time of writing however as PGT is a rapidly advancing technology it is important to check information with your fertility specialist.
Among embryos created in a laboratory some have too many and some have too few chromosomes. This is called aneuploidy. Embryos can also have genetic defects which can cause health problems in a child. Preimplantation genetic testing (PGT) is used to select embryos with the right number of chromosomes and those that do not have defective genes. There are two types of PGT: